Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-12

Clinical Trial Update: A Study With Pentasa in Patients With Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial of Pentasa in active Crohn's disease was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Crohn´s Disease | Phase 3 | Status: TERMINATED | Results posted: 2012-03-12